Paragon Associates & Paragon Associates Ii Joint Venture Iridex Corp Put Options Transaction History
Paragon Associates & Paragon Associates Ii Joint Venture
- $39.7 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IRIX
# of Institutions
23Shares Held
3.09MCall Options Held
0Put Options Held
2K-
Vanguard Group Inc Valley Forge, PA595KShares$844,5970.0% of portfolio
-
Amh Equity LTD519KShares$736,3280.83% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny379KShares$538,4070.0% of portfolio
-
Geode Capital Management, LLC Boston, MA133KShares$189,0090.0% of portfolio
-
Ars Investment Partners, LLC110KShares$156,2850.01% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $22.7M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...